You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

288 Results
Regimen
Cancer Type:
Hematologic, 
Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Bortezomib - Relapsed or Refractory Multiple Myeloma
ODB - General Benefit
    dexamethasone
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
belantamab mafodotin (Compassionate),
bortezomib,
dexamethasone
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2025
Drug
Other Name(s): Epkinly™
Quick Link(s):
Drug Monograph, Patient Info Sheet
Updated
Aug 2025
Drug
Other Name(s): Kimmtrak®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Updated
Aug 2025
Drug
Other Name(s): Camptosar®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Updated
Aug 2025
Drug
Other Name(s): Neulasta®, Lapelga®, Fulphila™; Ziextenzo®; Nyvepria™, Niopeg®, Pexegra™
Quick Link(s):
Drug Monograph, Patient Info Sheet
Updated
Aug 2025
Drug
Other Name(s): Femara®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Updated
Aug 2025
Drug
Other Name(s): Scemblix™
Quick Link(s):
Drug Monograph, Patient Info Sheet
Updated
Aug 2025
Drug
Other Name(s): Tykerb®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Updated
Aug 2025
Drug
Other Name(s): Caelyx®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Updated
Aug 2025
Guidelines and Advice
Status: Current
Updated
Aug 2025
Drug
Other Name(s): Vidaza®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Updated
Sep 2025
Drug
Other Name(s): Keytruda®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Updated
Sep 2025

Pages